Quick Answer
Arteris, Inc. reported Stockholders Equity of -$14.63 million for the year ending 2025.
- Arteris, Inc. showed a decrease of -1,131.6% in Stockholders Equity from 2024 to 2025.
- This data is from Arteris, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: -$16.16 million | Q3 2020: -$19.87 million | Q1 2021: -$18.21 million | Q2 2021: -$16.19 million | Q3 2021: -$20.69 million | Q1 2022: $47.66 million | Q2 2022: $45.71 million | Q3 2022: $40.36 million | Q1 2023: $31.77 million | Q2 2023: $26.92 million | Q3 2023: $22.03 million | Q1 2024: $9.55 million | Q2 2024: $5.28 million | Q3 2024: $2.21 million | Q1 2025: -$4.82 million | Q2 2025: -$7.53 million | Q3 2025: -$11.45 million.
- Over the full 7 years of available data (2019 to 2025), Arteris, Inc.'s Stockholders Equity has declined by 55.2%.
- Historical annual values: Fiscal year 2025: -$14.63 million | Fiscal year 2024: -$1.19 million | Fiscal year 2023: $15.10 million | Fiscal year 2022: $37.54 million | Fiscal year 2021: $52.90 million | Fiscal year 2020: -$12.01 million | Fiscal year 2019: -$9.43 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: